Tue, August 1, 2023
Mon, July 31, 2023
Sun, July 30, 2023
Fri, July 28, 2023

Paul Choi Maintained (URGN) at Hold with Increased Target to $18 on, Jul 31st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-18-on-jul-31st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Paul Choi of Goldman Sachs, Maintained "UroGen Pharma Ltd." (URGN) at Hold with Increased Target from $11 to $18 on, Jul 31st, 2023.

Paul has made no other calls on URGN in the last 4 months.



There are 2 other peers that have a rating on URGN. Out of the 2 peers that are also analyzing URGN, 0 agree with Paul's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Paul


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $23 on, Wednesday, June 21st, 2023
  • Leland Gershell of "Oppenheimer" Reiterated at Buy and Held Target at $22 on, Monday, May 15th, 2023

Publication Contributing Sources